Posted by Sten Westgard, MS
Pardon our political incorrectness: at the 2015 AACC/ASCLS conference, there were about as many different presentations on IQCP as there are GOP presidential candidates. With about the same amount of coherence. As US labs near the IQCP deadline, confusion is mounting, not consensus. (If you need to develop an IQCP and this isn't worrying you, you're not paying attention.)
Is it time to panic? Or time to proactively plan?
Last month we took a look at one control and a series of values that were designed to break almost all the "Westgard Rules." Here are the answers and your opportunity to compare your findings with our results.
When you have values from just one control, what rules can't be broken?
When a point-of-care device is compared to a core laboratory analyzer, we assume the core laboratory analyzer is always "right". But what if we can't tell whether either the point-of-care method or the core lab method is correct? When methodology is not the same, how do you handle the differences and bias between devices?
Between the core lab and POC, who do you decide is "right"?
When you subscribe to the blog, we will send you an e-mail when there are new updates on the site so you wouldn't miss them.
Comments